Name : MR.

LALLAN Sample Collection : 18/03/2025 10:34 AM

Age/Sex : 63Years /Male Sample Received : 18/03/2025 10:58 AM
Ref. By : Dr. DH Report Released : 18/03/2025 06:15 PM
Sent By : Gaurav Collection Point LAB ID : 2503511

CBC ( COMPLETE BLOOD COUNT )

Test Description Result Unit Biological Reference Ranges
CBC ( Complete Blood Count )
Haemoglobin 11.3 gm/dL 13.0 - 17.0
Method: Photometry

Total Wbc Count 4950 cell/cu.mm 4000 - 10000

Method: Flowcytometry

RBC Count 4.20 mil/cu.mm 4.5 - 5.5

RBC INDICES
Hematocrit HCT 33.1 % 40 - 50
Method: Calculated

Mean Corp Volume MCV 78.8 fL 83 - 101

Method: Flowcytometry

Mean Corp Hb MCH 26.9 pg 27 - 32

Method: Calculated

Mean Corp Hb Conc MCHC 34.1 gm/dL 31.5 - 34.5

Method: Calculated

RDW-CV 16.0 % 11.6 - 14.0

Method: Flowcytometry

RDW-SD 34.7 fL 37.0 - 54.0

Method: Flowcytometry

Platelet Count 80000 cells/cmm 150000 - 450000

Method: Flowcytometry
Platelet Indices
MPV 15.8 fL 9.0 - 13.0
Method: Flowcytometry

PDW 26.5 fL 9.9 - 17.0

Method: Flowcytometry

PCT 0.08 % 0.17 - 0.35

Method: Flowcytometry

P-LCR 65.83 % 13.0 - 43.0

DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils 68 % 40 - 80
Method: Flowcytometry

Lymphocytes 18 % 20 - 40
Method: Flowcytometry

Monocytes 09 % 02 - 10
Method: Flowcytometry

Dr Vigyan Mishra
MD PATH., TCMD MOLECULAR
DIAG (GOLD MEDALIST)
Consultant Pathologist

Page 1 of 8
Name : MR PRADEEP Sample Collection : 18/03/2025 10:34 AM
Age/Sex : 63Years /Male Sample Received : 18/03/2025 10:58 AM
Ref. By : Dr. DH Report Released : 18/03/2025 06:15 PM
Sent By : Gaurav Collection Point LAB ID : 2503511

Eosinophils 05 % 01 - 06
Method: Flowcytometry

Basophils 00 % 01 - 02
Method: Flowcytometry
Absolute Differential Count
Absolute Neutrophils Count 3366 /cumm 2000 - 7000
Method: Calculated

Absolute Lymphocyte Count 891 /cumm 1000 - 3000

Method: Calculated

Absolute Eosinophil Count 248 /cumm 40 - 440

Method: Calculated

Absolute Monocyte Count 446 /cumm 200 - 1000

Method: Calculated

Dr Vigyan Mishra
MD PATH., TCMD MOLECULAR
DIAG (GOLD MEDALIST)
Consultant Pathologist

Page 2 of 8
Name : MR PRADEEP Sample Collection : 18/03/2025 10:34 AM
Age/Sex : 63Years /Male Sample Received : 18/03/2025 10:58 AM
Ref. By : Dr. DH Report Released : 18/03/2025 06:15 PM
Sent By : Gaurav Collection Point LAB ID : 2503511

HBA1C- GLYCATED HAEMOGLOBIN

Test Description Result Unit Biological Reference Ranges
HbA1c- Glycated Haemoglobin
HbA1c Glycosilated Haemoglobin 6.2 % <5.7
Method: HPLC, NGSP certified

Estimated Average Glucose : 131 mg/dL

As per American Diabetes Association (ADA) ADA criteria for correlation

Reference Group HbA1c in % HbA1c(%)Mean Plasma Glucose (mg/dL)

Non diabetic adults >=18 years <5.7 6 126
At risk (Prediabetes) 5.7 - 6.4 7 154
Diagnosing Diabetes >= 6.5 8 183
Age > 19 years 9 212
Goal of therapy: < 7.0
10 240
Therapeutic goals for glycemic control Action suggested: > 8.0
11 269
Age < 19 years
Goal of therapy: <7.5 12 298
Note:
1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may
still have a high concentration of HbA1c. Converse is true for a diabetic previously under good control but now poorly controlled .
2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant cardiovascular
disease. In patients with significant complications of diabetes, limited life expectancy or
extensive co-morbid conditions, targeting a goal of < 7.0 % may not be appropriate.
Comments:HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better indicator of long term
glycemic control as compared to blood and urinary glucose determinations.

Dr Vigyan Mishra
MD PATH., TCMD MOLECULAR
DIAG (GOLD MEDALIST)
Consultant Pathologist

Page 3 of 8
Name : MR PRADEEP Sample Collection : 18/03/2025 10:34 AM
Age/Sex : 63Years /Male Sample Received : 18/03/2025 10:58 AM
Ref. By : Dr. DH Report Released : 18/03/2025 06:15 PM
Sent By : Gaurav Collection Point LAB ID : 2503511

KFT ( KIDNEY FUNCTION TEST )

Test Description Result Unit Biological Reference Ranges
KFT ( Kidney Function Test )
Serum Creatinine 1.10 mg/dL 0.70 - 1.30
Method: Modified Jaffe with no deproteinzation

Urea 22.0 mg/dl 10.0 - 45.0

Method: Urease UV GLDH

Blood Urea Nitrogen-BUN 8.8 mg/dl 7 - 20

Method: Calculated

Uric Acid 6.75 mg/dl 3.6 - 7.7

Method: Uricase Peroxidase

Calcium 9.82 mg/dl 8.5 - 10.7

Method: Arsenazo III

Phosphrous-serum 2.95 mg/dl 2.5 - 4.5

Sodium 137.3 mmol/L 135 - 146
Method: ISE

Potassium 5.51 mmol/L 3.5 - 5.5

Method: ISE

Ionic Calcium 1.15 mEq/L 1.0 - 1.32

Method: ISE
Interpretation :
Kidney function tests help to screen the individual for renal disease and to determine the extent or progression of renal disease. These tests
also aid in determining drug dosage for drugs excreted through the kidneys. The clinical syndrome resulting from decreased renal function and
azotemia is called uremia Renal azotemia: glomerular nephritis and chronic pyelonephritis. Prerenal azotemia: severe dehydration,
hemorrhagic shock, and excessive protein intake. Post renal azotemia: urethral stones or tumors and prostatic obstructions Measurement of
urea in dialysis fluids is widely used in assessing the adequacy of renal replacement therapy.
In these prerenal situations, the plasma creatinine concentration may be normal.In obstructive post renal conditions, both plasma creatinine
and urea concentrations will be increased, although there is often a greater increase in plasma urea than creatinine because of the increased
back diffusion.These considerations give rise to the principal clinical utility of plasma urea, which lies in its measurement in conjunction with
that of plasma creatinine and subsequent calculation of the urea nitrogen/creatinine ratio. This ratio has been used as a crude discriminator
between prerenal and postrenal azotemia. Significantly lower ratios usually denote (1) acute tubular necrosis, (2) low protein intake, (3)
starvation, or (4) severe liver disease (decreased urea synthesis). So even though blood urea is not an excellent marker of renal dysfunction
as it rises quite late in the dysfunction and its rise is also not exclusive to kidney dysfunction, but for practical purposes serum urea level is still
one of the most ordered test and forms an important part of the kidney function test.
Concentrations in excess of 6.0 mg/dL at 32 weeks gestation have been noted to be associated with a high perinatal mortality rate.

Dr Vigyan Mishra
MD PATH., TCMD MOLECULAR
DIAG (GOLD MEDALIST)
Consultant Pathologist

Page 4 of 8
Name : MR PRADEEP Sample Collection : 18/03/2025 10:34 AM
Age/Sex : 63Years /Male Sample Received : 18/03/2025 10:58 AM
Ref. By : Dr. DH Report Released : 18/03/2025 06:15 PM
Sent By : Gaurav Collection Point LAB ID : 2503511

BLOOD SUGAR RANDOM

Test Description Result Unit Biological Reference Ranges
Blood Sugar Random
BLOOD SUGAR= RANDOM 233.0 mg/dl 70 - 160
Method: Hexokinase
ADA 2019 Guideline:
Diabetes mellitus: Random plasma glucose > 200
(More than one occasion)

Dr Vigyan Mishra
MD PATH., TCMD MOLECULAR
DIAG (GOLD MEDALIST)
Consultant Pathologist

Page 5 of 8
Name : MR PRADEEP Sample Collection : 18/03/2025 10:34 AM
Age/Sex : 63Years /Male Sample Received : 18/03/2025 10:58 AM
Ref. By : Dr. DH Report Released : 18/03/2025 06:15 PM
Sent By : Gaurav Collection Point LAB ID : 2503511

BIOCHEMISTRY ROUTINE REPORT

Test Description Result Unit Biological Reference Ranges

URIC ACID 6.75 mg/dl 3.6 - 7.7

Interpretation
Uric Acid - Serum uric acid measurements are useful in the diagnosis and treatment of numerous renal and metabolic disorders, including
renal failure, gout, leukemia, psoriasis, starvation or other wasting conditions, and in patients receiving cytotoxic drugs.

LFT ( LIVER FUNCTION TEST )1 MAXI

Test Description Result Unit Biological Reference Ranges
LFT ( Liver Function Test )1
TOTAL BILIRUBIN 0.57 mg/dl 0.1 -1.2
Method: Jendrassik Grof

DIRECT BILIRUBIN 0.20 mg/dL 0.0 -0.3

Method: Diazotization

INDIRECT BILIRUBIN 0.37 mg/dl 0.0 -0.9

Method: Calculated

SGPT (ALT) 20.0 U/L 0 - 49

Method: UV with P5P, IFCC 37 degree

SGOT (AST) 21.0 U/L 0 - 46

Method: UV with P5P, IFCC 37 degree

ALKALINE PHOSPHATASE 46.0 U/L 30 - 120

Method: DGKC

TOTAL PROTEIN 6.3 g/dl 6.0 - 8.0

Method: Biuret, reagent blank end point

SERUM ALBUMIN 3.25 g/dl 3.2 - 4.6

Method: Bromocresol green

SERUM GLOBULIN 3.05 g/dl 1.8 - 3.6

Method: Calculated

A/G RATIO 1.07 1.2 - 2.2

Method: Calculated
NOTE :
In known cases of Chronic Liver disease due to Viral Hepatitis B & C, Alcoholic liver disease or Non alcoholic fatty liver disease, Enhanced
liver fibrosis (ELF) test may be used to evaluate liver fibrosis.

Dr Vigyan Mishra
MD PATH., TCMD MOLECULAR
DIAG (GOLD MEDALIST)
Consultant Pathologist

Page 6 of 8
Name : MR PRADEEP Sample Collection : 18/03/2025 10:34 AM
Age/Sex : 63Years /Male Sample Received : 18/03/2025 10:58 AM
Ref. By : Dr. DH Report Released : 18/03/2025 06:15 PM
Sent By : Gaurav Collection Point LAB ID : 2503511

URINE ROUTINE EXAMINATION

Test Description Result Unit Biological Reference Ranges

Urine Routine Examination

Physical Examination

Quantity 20ml ml

Colour Pale Yellow

Apperance Clear

Specific Gravity 1.010

Chemical Examination

Occult Blood Absent

Sugar Present (+)

Protein Trace

Ketone Bodies Absent

Bile Salt Absent

Reaction(pH) 6.0(Alkaline)

Microscopic Examination

Bacteria Not seen

Epithelial Cells 2-4/hpf /hpf

Pus cells 6-8/hpf /hpf

RBC's Not seen /hpf

Casts Not Seen

Dr Vigyan Mishra
MD PATH., TCMD MOLECULAR
DIAG (GOLD MEDALIST)
Consultant Pathologist

Page 7 of 8
Name : MR PRADEEP Sample Collection : 18/03/2025 10:34 AM
Age/Sex : 63Years /Male Sample Received : 18/03/2025 10:58 AM
Ref. By : Dr. DH Report Released : 18/03/2025 06:15 PM
Sent By : Gaurav Collection Point LAB ID : 2503511

Crystals NOT FOUND

Yeast Cells NOT FOUND

**** End of the report. ****

Dr Vigyan Mishra
MD PATH., TCMD MOLECULAR
DIAG (GOLD MEDALIST)
Consultant Pathologist

Page 8 of 8